Comparing the Long-term Cost-effectiveness of Repaglinide Plus Metformin Versus Nateglinide Plus Metformin in Type 2 Diabetes Patients with Inadequate Glycaemic Control: An Application of the CORE Diabetes Model in Type 2 Diabetes

2004 ◽  
Vol 20 (sup1) ◽  
pp. S41-S51 ◽  
Author(s):  
Andrew J. Palmer ◽  
Stéphane Roze ◽  
Morten Lammert ◽  
William J. Valentine ◽  
Michael E. Minshall ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
Cost Effectiveness ◽  
Glycaemic Control ◽  
The Core ◽  
Diabetes Model ◽  
Diabetes Patients

Impact of Changes in HbA1c, Lipids and Blood Pressure on Long-term Outcomes in Type 2 Diabetes Patients: An Analysis Using the CORE Diabetes Model

2004 ◽  
Vol 20 (sup1) ◽  
pp. S53-S58 ◽  
Author(s):  
Andrew J. Palmer ◽  
Stéphane Roze ◽  
William J. Valentine ◽  
Michael E. Minshallb ◽  
Clarice Hayes ◽  
...  
Keyword(s):  
Blood Pressure ◽  
Type 2 Diabetes ◽  
Long Term Outcomes ◽  
The Core ◽  
Diabetes Model ◽  
Diabetes Patients

968-P: Long-Term Quantitative and Qualitative Effect of Dulaglutide in Type 2 Diabetes Patients

Diabetes ◽  
2020 ◽  
Vol 69 (Supplement 1) ◽  
pp. 968-P
Author(s):  
ANASTASIOS KOUTSOVASILIS ◽  
ALEXIOS SOTIROPOULOS ◽  
MARIA PAPPA ◽  
THEODOROS PEPPAS
Keyword(s):  
Type 2 Diabetes ◽  
Qualitative Effect ◽  
Diabetes Patients
Sign in / Sign up

Export Citation Format

Share Document